Catalent, Inc.
SEC CIK 1596783 · CTLT · last insider filing 2024-12-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Stahl Jack L | Director | filed 2014 - 2024 |
| Classon Rolf A | Director | filed 2014 - 2024 |
| Damelio Frank A | Director | filed 2023 - 2024 |
| Morel Donald E JR | Director | filed 2015 - 2024 |
| Lucier Gregory T | Director | filed 2015 - 2024 |
| Greisch John J | Director · Executive Chair | filed 2018 - 2024 |
| Carroll J Martin | Director | filed 2015 - 2024 |
| Maselli Alessandro | Director · See remarks | filed 2016 - 2024 |
| Okey Stephanie | Director | filed 2023 - 2024 |
| Barg Steven | Director | filed 2023 - 2024 |
| Barber Michael J | Director | filed 2021 - 2024 |
| Ryan Michelle R | Director | filed 2023 - 2024 |
| Kreuzburg Christa | Director | filed 2018 - 2024 |
| Crane Rosemary A | Director | filed 2018 - 2023 |
| Flynn Karen | Director · Pres. Biologics & CCO | filed 2020 - 2023 |
| Balachandran Madhavan | Director | filed 2017 - 2023 |
| Zippelius Peter | Director | filed 2019 - 2022 |
| Chiminski John R | Director · See Remarks | filed 2014 - 2022 |
| Roehrhoff Uwe | Director | filed 2016 - 2017 |
| Quella James | Director | filed 2014 - 2017 |
| Booth Melvin D | Director | filed 2014 - 2016 |
| Chu Chinh | Director | filed 2014 - 2014 |
| Mcevoy Bruce | Director | filed 2014 - 2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Masanovich Matti | SVP, Chief Financial Officer | filed 2023 - 2024 |
| Gennadios Aristippos | See Remarks | filed 2014 - 2024 |
| Evoli Lisa | SVP, Chief HR Officer | filed 2023 - 2024 |
| Gunther Scott | See Remarks | filed 2017 - 2024 |
| Ferraro Joseph Anthony | SVP, General Counsel, CCO | filed 2023 - 2024 |
| Hatzfeld Michael | Chief Accounting Officer | filed 2024 - 2024 |
| Hopson Ricky | VP, Chief Accounting Officer | filed 2021 - 2024 |
| Mcerlane David | Group President, Biologics | filed 2023 - 2024 |
| Fasman Steven L | See Remarks | filed 2014 - 2023 |
| Arnold Jonathan | SVP, CCO & Div. Head BioP Del. | filed 2017 - 2023 |
| Pravda Ricardo | SVP, Human Resources | filed 2019 - 2023 |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | filed 2019 - 2023 |
| Carletti Lorenzo | SVP Global Ops Small Molecule | filed 2021 - 2023 |
| Hawkeswood Thomas W | Pres. Pharma Prod Delivery Div | filed 2022 - 2023 |
| Hunt Patricia | Pres. Consumer Health Div | filed 2022 - 2023 |
| Lickfold Charles | SVP, CIO | filed 2022 - 2023 |
| Zayas Ricardo | SVP, Operations, Biologics NA | filed 2023 - 2023 |
| Santiago Karen Murphy | VP & Chief Accounting Officer | filed 2022 - 2023 |
| Gargiulo Mario | SVP, Ops, Biologics Europe | filed 2021 - 2023 |
| Boerman Manja | Pres. BioModalities Division | filed 2022 - 2023 |
| Riley Michael A. | Pres. Bio Product Delivery Div | filed 2022 - 2022 |
| Schmidt Kay A | SVP, Technical Operations | filed 2019 - 2022 |
| Castellano Thomas P | SVP, Chief Financial Officer | filed 2021 - 2022 |
| Whitlow Ricci S | President, CSS | filed 2020 - 2022 |
| Joseph Wetteny | See Remarks | filed 2015 - 2021 |
| Buzy Peter L | President, Gene Therapy | filed 2019 - 2020 |
| Littlejohns Barry | See Remarks | filed 2014 - 2019 |
| Hegwood Paul W JR | President, CSS | filed 2018 - 2019 |
| Miyamoto Lance | See Remarks | filed 2014 - 2019 |
| Downie William | See Remarks | filed 2014 - 2019 |
| Dolan Christine | See Remarks | filed 2016 - 2017 |
| Walsh Matthew M | See Remarks | filed 2014 - 2017 |
| Johnson Sharon | See Remarks | filed 2014 - 2017 |
| Leonard Stephen | See Remarks | filed 2014 - 2016 |
| Houlton Scott | See Remarks | filed 2014 - 2015 |
| Kurt Nielsen | See Remarks | filed 2014 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.